Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-06

Clinical Trial Update: Effect of MiYOSMART iQ Spectacle Lenses on Myopia Progression in Children [NA]

View source ↗

Summary

An update on an ongoing clinical trial evaluating MiYOSMART iQ spectacle lenses for slowing myopia progression in children; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MiYOSMART iQ Spectacle Lenses

Snippet

Sponsor: Hoya Lens Rus LLC | Conditions: Myopia, Child Myopia Progression | NA | Status: RECRUITING